Corporate Events
Board MeetingMYGN
20266Nov
Board Meeting
Executive Retention Stock Option Awards approved for certain…
SEC Filing ↗ Board MeetingMYGN
20264Nov
Board Meeting
Myriad Genetics, Inc. to hold its third quarter 2026 earning…
SEC Filing ↗ Board MeetingMYGN
202616Sep
Board Meeting
Vishal Sikri promoted to Executive Vice President - Commerci…
SEC Filing ↗ Board MeetingMYGN
202630Jul
Board Meeting
Second Quarter 2026 Earnings Conference Call and Business Up…
SEC Filing ↗ Board MeetingMYGN
202617Jun
Board Meeting
Director Resignation — Daniel M. Skovronsky M.D., Ph.D. resi…
SEC Filing ↗ Board MeetingMYGN
20264Jun
Board Meeting
Myriad Genetics Inc. held its 2026 Annual Meeting of Stockho…
SEC Filing ↗ Board MeetingMYGN
20261Jun
Board Meeting
CTO Appointment — Raj Jampa appointed as Chief Technology Of…
SEC Filing ↗